Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Schizotypal Personality Disorder

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Schizotypal Personality Disorder in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Schizotypal Personality Disorder: A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Dam, NT1
Earleywine, M1
DiGiacomo, G1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Schizotypal Personality Disorder

ArticleYear
Polydrug use, cannabis, and psychosis-like symptoms.
    Human psychopharmacology, 2008, Volume: 23, Issue:6

    Topics: Adult; Central Nervous System Stimulants; Cognition; Female; Humans; Male; Marijuana Abuse; N-Methyl

2008